Decitabine-primed Tandem CD19/CD20 CAR T Cells Plus Epigenetic Agents in Aggressive r/r B-NHL With Huge Tumor Burden
Clinical trial NCT04553393 · UNKNOWN
Trial details
- NCT number
- NCT04553393
- Sponsor
- Chinese PLA General Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-09
- Primary completion
- 2021-09-08
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.